{"id":13848,"date":"2025-06-23T08:00:09","date_gmt":"2025-06-23T06:00:09","guid":{"rendered":"https:\/\/www.cilcare.com\/?p=13848"},"modified":"2025-06-23T11:05:14","modified_gmt":"2025-06-23T09:05:14","slug":"cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders","status":"publish","type":"post","link":"https:\/\/www.cilcare.com\/jp\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/","title":{"rendered":"Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders"},"content":{"rendered":"<p><strong>Cilcare <\/strong>is pleased to announce that its innovative <strong>INEAR3D project <\/strong>has been selected by the<strong> <a href=\"https:\/\/www.umontpellier.fr\/en\/innovation\/partenariats-universite-entreprise\/companies-and-campus\">Companies &amp; Campus initiative<\/a><\/strong>, supported by the<strong> <a href=\"https:\/\/www.umontpellier.fr\/en\/\">University of Montpellier<\/a><\/strong> and its <a href=\"https:\/\/www.umontpellier.fr\/en\/innovation\/pole-universitaire-dinnovation\/booster-innovation-montpellier-b-i-m\"><strong>P\u00f4le Universitaire d\u2019Innovation (PEI)<\/strong><\/a>. The project has received a \u20ac50,000 grant in recognition of its scientific impact and alignment with the PEI\u2019s health and sustainability priorities.<\/p>\n\n\n\n<p>Led by <strong>Dr. Sylvie Pucheu<\/strong>, Director of Preclinical Innovation at Cilcare, INEAR3D represents a bold leap forward in the development of <strong>human-based <em>in vitro<\/em> models<\/strong> for auditory drug screening. The project is carried out in collaboration with the<strong> <a href=\"https:\/\/www.icgm.fr\/en\/icgm-umr5253-english\/\">Institut Charles Gerhardt de Montpellier (ICGM)<\/a>,<\/strong> combining academic and industry expertise to advance precision tools in hearing research.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h1 class=\"wp-block-heading\"><strong>\ud83c\udfaf Why the INEAR3D Project Matters<\/strong><\/h1>\n\n\n\n<p>Hearing loss is the most common sensory disorder in humans and a major public health issue worldwide. Yet, the effectiveness of auditory treatments remains limited, particularly due to challenges in drug delivery to the inner ear. The <strong>round window membrane (RWM)<\/strong> acts as a critical biological barrier between the middle and inner ear, limiting the diffusion and bioavailability of active pharmaceutical compounds.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&#8220;<em>The inaccessibility of the cochlea and lack of human cellular models are two major barriers to developing effective treatments for sensorineural hearing loss,\u201d<\/em> says Dr. Sylvie Pucheu. <em>\u201cWith INEAR3D, we aim to overcome these limitations by providing a <strong>highly reliable, human-cell-derived platform<\/strong> that more accurately reflects human biology than traditional animal models. This biomimetic tool will enable us to better study and predict how drugs pass through the complex membranes of the inner ear.<\/em>&#8220;<\/p>\n<\/blockquote>\n\n\n\n<h1 class=\"wp-block-heading\"><strong><strong>\ud83e\uddea A 3D Bioprinted Model to Replace Animal Testing<\/strong><\/strong><\/h1>\n\n\n\n<p>INEAR3D proposes to <strong>reconstruct the round window membrane using advanced 3D bioprinting technologies<\/strong>, specifically stereolithography DLP (Digital Light Processing). The printed hydrogel structure will mimic the native membrane&#8217;s multilayer composition, incorporating specific human cell types and extracellular matrix properties. This <em>in vitro<\/em> model will allow high-throughput testing of drug diffusion and formulation strategies.<\/p>\n\n\n\n<p>The goal is not only to accelerate drug development but also to <strong>reduce animal testing<\/strong> in line with the 3Rs principle (Replace, Reduce, Refine).<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u201cThis model will allow us to test compounds and biotherapies more ethically and more efficiently, ultimately accelerating the discovery of new hearing loss therapies,\u201d<\/em> adds Dr. Pucheu.<\/p>\n<\/blockquote>\n\n\n\n<h1 class=\"wp-block-heading\"><strong><strong><strong>\ud83d\ude80 Toward Innovation and Translation<\/strong><\/strong><\/strong><\/h1>\n\n\n\n<p>By integrating Cilcare\u2019s preclinical expertise with cutting-edge materials science, INEAR3D is expected to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Enable <strong>quantitative analysis of drug permeability<\/strong> through the RWM<\/li>\n\n\n\n<li>Improve early-stage <strong>screening of formulations and excipients<\/strong><\/li>\n\n\n\n<li>Serve as a <strong>predictive tool<\/strong> to complement <em>in vivo<\/em> models<\/li>\n\n\n\n<li>Support regulatory data packages for <strong>CTA\/IND filings<\/strong><\/li>\n<\/ul>\n\n\n\n<p>INEAR3D exemplifies Cilcare\u2019s commitment to scientific excellence and disruptive innovation in auditory research. The project includes the recruitment of a CIFRE PhD student and further strengthens our contribution to the dynamic biotech innovation ecosystem in Occitanie.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-text-align-center\"><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Cilcare is pleased to announce that its innovative INEAR3D project has been selected by the Companies &amp; Campus initiative, supported by the University of Montpellier and its P\u00f4le Universitaire d\u2019Innovation (PEI). The project has received a \u20ac50,000 grant in recognition of its scientific impact and alignment with the PEI\u2019s health and sustainability priorities. Led by Dr. Sylvie Pucheu, Director of Preclinical Innovation at Cilcare, INEAR3D represents a bold leap forward in the development of human-based in vitro models for auditory drug screening. The project is carried out in collaboration with the Institut Charles Gerhardt de Montpellier (ICGM), combining academic and industry expertise to advance precision tools in hearing research. \ud83c\udfaf [&hellip;]<\/p>","protected":false},"author":6,"featured_media":13852,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[114],"tags":[134],"class_list":["post-13848","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","tag-cilcare-launches-a-new-study-to-explore-hearing-in-patients-with-early-stage-neurodegenerative-diseases-and-identify-new-auditory-biomarkers","entry","has-media"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders - Cilcare<\/title>\n<meta name=\"description\" content=\"\u20ac40 million series A completed to accelerate development of innovative treatments for early hearing loss\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cilcare.com\/jp\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders - Cilcare\" \/>\n<meta property=\"og:description\" content=\"\u20ac40 million series A completed to accelerate development of innovative treatments for early hearing loss\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cilcare.com\/jp\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"Cilcare\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-23T06:00:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-23T09:05:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/06\/Image5.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"957\" \/>\n\t<meta property=\"og:image:height\" content=\"706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"marie.peytavy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"marie.peytavy\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/\",\"url\":\"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/\",\"name\":\"Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders - Cilcare\",\"isPartOf\":{\"@id\":\"https:\/\/www.cilcare.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/06\/Image5.jpg\",\"datePublished\":\"2025-06-23T06:00:09+00:00\",\"dateModified\":\"2025-06-23T09:05:14+00:00\",\"author\":{\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/345b0ccb59d96b17a6908a76cad8e256\"},\"description\":\"\u20ac40 million series A completed to accelerate development of innovative treatments for early hearing loss\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#primaryimage\",\"url\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/06\/Image5.jpg\",\"contentUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/06\/Image5.jpg\",\"width\":957,\"height\":706},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cilcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cilcare.com\/#website\",\"url\":\"https:\/\/www.cilcare.com\/\",\"name\":\"Cilcare\",\"description\":\"Making hearing a priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cilcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/345b0ccb59d96b17a6908a76cad8e256\",\"name\":\"marie.peytavy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5de15f4de6ecabd3b374a0d5608780aae06de6510a1b70c8fdf69e014f99cfbc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5de15f4de6ecabd3b374a0d5608780aae06de6510a1b70c8fdf69e014f99cfbc?s=96&d=mm&r=g\",\"caption\":\"marie.peytavy\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders - Cilcare","description":"\u20ac40 million series A completed to accelerate development of innovative treatments for early hearing loss","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cilcare.com\/jp\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/","og_locale":"ja_JP","og_type":"article","og_title":"Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders - Cilcare","og_description":"\u20ac40 million series A completed to accelerate development of innovative treatments for early hearing loss","og_url":"https:\/\/www.cilcare.com\/jp\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/","og_site_name":"Cilcare","article_published_time":"2025-06-23T06:00:09+00:00","article_modified_time":"2025-06-23T09:05:14+00:00","og_image":[{"width":957,"height":706,"url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/06\/Image5.jpg","type":"image\/jpeg"}],"author":"marie.peytavy","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"marie.peytavy","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/","url":"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/","name":"Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders - Cilcare","isPartOf":{"@id":"https:\/\/www.cilcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#primaryimage"},"image":{"@id":"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/06\/Image5.jpg","datePublished":"2025-06-23T06:00:09+00:00","dateModified":"2025-06-23T09:05:14+00:00","author":{"@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/345b0ccb59d96b17a6908a76cad8e256"},"description":"\u20ac40 million series A completed to accelerate development of innovative treatments for early hearing loss","breadcrumb":{"@id":"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#primaryimage","url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/06\/Image5.jpg","contentUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/06\/Image5.jpg","width":957,"height":706},{"@type":"BreadcrumbList","@id":"https:\/\/www.cilcare.com\/2025\/06\/23\/cilcare-launches-a-groundbreaking-3d-bioprinting-project-with-human-cells-to-advance-therapies-for-hearing-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cilcare.com\/"},{"@type":"ListItem","position":2,"name":"Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders"}]},{"@type":"WebSite","@id":"https:\/\/www.cilcare.com\/#website","url":"https:\/\/www.cilcare.com\/","name":"Cilcare","description":"Making hearing a priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cilcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/345b0ccb59d96b17a6908a76cad8e256","name":"marie.peytavy","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5de15f4de6ecabd3b374a0d5608780aae06de6510a1b70c8fdf69e014f99cfbc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5de15f4de6ecabd3b374a0d5608780aae06de6510a1b70c8fdf69e014f99cfbc?s=96&d=mm&r=g","caption":"marie.peytavy"}}]}},"_links":{"self":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/13848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/comments?post=13848"}],"version-history":[{"count":6,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/13848\/revisions"}],"predecessor-version":[{"id":13856,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/13848\/revisions\/13856"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media\/13852"}],"wp:attachment":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media?parent=13848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/categories?post=13848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/tags?post=13848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}